http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 02 Aug 2024 16:06:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VBI+Vaccines+IncBC+++++++For%3A+Jul+30/23546389.html si-local-file:///var/storage/secattach/20240802/23546389.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VBI+Vaccines+IncBC+++++++For%3A+Jul+30/23546389.html Fri, 02 Aug 2024 16:06:00 -0400 O.00063920 VBIV http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VBI+Vaccines+IncBC+++++++For%3A+Jul+30/23546389.html si-local-file:///var/storage/secattach/20240802/23546389.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VBI+Vaccines+IncBC+++++++For%3A+Jul+30/23546389.html Fri, 02 Aug 2024 16:06:00 -0400 O.00063920 VBIV http://www.streetinsider.com/Guidance/VBI+Vaccines+%28VBIV%29+Provides+an+Update+on+its+Restructuring+Proceedings/23546339.html <p>VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024.</p><p><i>U.S. Chapter 15 Filing </i><br />On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (“Initial Order”), which granted the company protection under the <i>Companies’ Creditors Arrangement Act</i>, R.S.C. http://www.streetinsider.com/Guidance/VBI+Vaccines+%28VBIV%29+Provides+an+Update+on+its+Restructuring+Proceedings/23546339.html Fri, 02 Aug 2024 16:05:45 -0400 VBIV http://www.streetinsider.com/Corporate+News/VBI+Vaccines+%28VBIV%29+Provides+an+Update+on+its+Restructuring+Proceedings/23546339.html <p>VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024.</p><p><i>U.S. Chapter 15 Filing </i><br />On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (“Initial Order”), which granted the company protection under the <i>Companies’ Creditors Arrangement Act</i>, R.S.C. http://www.streetinsider.com/Corporate+News/VBI+Vaccines+%28VBIV%29+Provides+an+Update+on+its+Restructuring+Proceedings/23546339.html Fri, 02 Aug 2024 16:05:45 -0400 VBIV http://www.streetinsider.com/Management+Comments/VBI+Vaccines+%28VBIV%29+Provides+an+Update+on+its+Restructuring+Proceedings/23546339.html <p>VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024.</p><p><i>U.S. Chapter 15 Filing </i><br />On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (“Initial Order”), which granted the company protection under the <i>Companies’ Creditors Arrangement Act</i>, R.S.C. http://www.streetinsider.com/Management+Comments/VBI+Vaccines+%28VBIV%29+Provides+an+Update+on+its+Restructuring+Proceedings/23546339.html Fri, 02 Aug 2024 16:05:45 -0400 VBIV http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024. </p><p> <i>U.S. Chapter 15 Filing <br /></i>On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (“Initial Order”), which granted the company protection under the http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html Fri, 02 Aug 2024 16:05:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024. </p><p> <i>U.S. Chapter 15 Filing <br /></i>On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (“Initial Order”), which granted the company protection under the http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html Fri, 02 Aug 2024 16:05:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024. </p><p> <i>U.S. Chapter 15 Filing <br /></i>On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (“Initial Order”), which granted the company protection under the http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html Fri, 02 Aug 2024 16:05:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024. </p><p> <i>U.S. Chapter 15 Filing <br /></i>On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (“Initial Order”), which granted the company protection under the http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html Fri, 02 Aug 2024 16:05:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024. </p><p> <i>U.S. Chapter 15 Filing <br /></i>On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (“Initial Order”), which granted the company protection under the http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html Fri, 02 Aug 2024 16:05:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024. </p><p> <i>U.S. Chapter 15 Filing <br /></i>On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (“Initial Order”), which granted the company protection under the http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html Fri, 02 Aug 2024 16:05:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/Business+Wire/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024. </p><p> <i>U.S. Chapter 15 Filing <br /></i>On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (“Initial Order”), which granted the company protection under the http://www.streetinsider.com/Business+Wire/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html Fri, 02 Aug 2024 16:05:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/Business+Wire/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024. </p><p> <i>U.S. Chapter 15 Filing <br /></i>On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (“Initial Order”), which granted the company protection under the http://www.streetinsider.com/Business+Wire/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html Fri, 02 Aug 2024 16:05:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/Business+Wire/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024. </p><p> <i>U.S. Chapter 15 Filing <br /></i>On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (“Initial Order”), which granted the company protection under the http://www.streetinsider.com/Business+Wire/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html Fri, 02 Aug 2024 16:05:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/Business+Wire/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024. </p><p> <i>U.S. Chapter 15 Filing <br /></i>On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (“Initial Order”), which granted the company protection under the http://www.streetinsider.com/Business+Wire/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html Fri, 02 Aug 2024 16:05:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/Business+Wire/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024. </p><p> <i>U.S. Chapter 15 Filing <br /></i>On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (“Initial Order”), which granted the company protection under the http://www.streetinsider.com/Business+Wire/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html Fri, 02 Aug 2024 16:05:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/Business+Wire/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024. </p><p> <i>U.S. Chapter 15 Filing <br /></i>On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (“Initial Order”), which granted the company protection under the http://www.streetinsider.com/Business+Wire/VBI+Vaccines+Provides+an+Update+on+its+Restructuring+Proceedings/23546332.html Fri, 02 Aug 2024 16:05:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VBI+Vaccines+IncBC+++++++For%3A+Jul+29/23522719.html si-local-file:///var/storage/secattach/20240730/23522719.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VBI+Vaccines+IncBC+++++++For%3A+Jul+29/23522719.html Tue, 30 Jul 2024 10:28:00 -0400 O.00063920 VBIV http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VBI+Vaccines+IncBC+++++++For%3A+Jul+29/23522719.html si-local-file:///var/storage/secattach/20240730/23522719.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VBI+Vaccines+IncBC+++++++For%3A+Jul+29/23522719.html Tue, 30 Jul 2024 10:28:00 -0400 O.00063920 VBIV http://www.streetinsider.com/Corporate+News/VBI+Vaccines+%28VBIV%29+Initiates+Restructuring+Proceedings+Under+CCAA+to+Implement+a+Review+of+its+Strategic+Alternatives/23522387.html <p>VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that the Ontario Superior Court of Justice (Commercial List) (“Court”) has issued an initial order (“Initial Order”) granting the company protection under the <i>Companies’ Creditors Arrangement Act</i>, R.S.C. 1985, c. C-36, as amended (“CCAA”). The Initial Order provides for, among other things: (i) a stay of proceeding in favour of VBI, (ii) approval of the DIP Loan (as described below), and (iii) the appointment of Ernst & Young Inc. (“EY”) to serve as monitor (“Monitor”) in http://www.streetinsider.com/Corporate+News/VBI+Vaccines+%28VBIV%29+Initiates+Restructuring+Proceedings+Under+CCAA+to+Implement+a+Review+of+its+Strategic+Alternatives/23522387.html Tue, 30 Jul 2024 09:56:40 -0400 VBIV http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Initiates+Restructuring+Proceedings+Under+CCAA+to+Implement+a+Review+of+its+Strategic+Alternatives/23522379.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that the Ontario Superior Court of Justice (Commercial List) (“Court”) has issued an initial order (“Initial Order”) granting the company protection under the <i>Companies’ Creditors Arrangement Act</i>, R.S.C. 1985, c. C-36, as amended (“CCAA”). The Initial Order provides for, among other things: (i) a stay of proceeding in favour of VBI, (ii) approval of the DIP Loan (as described below), and (iii) the appointment of Ernst &amp; Young Inc. (“EY”) http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Initiates+Restructuring+Proceedings+Under+CCAA+to+Implement+a+Review+of+its+Strategic+Alternatives/23522379.html Tue, 30 Jul 2024 09:55:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Initiates+Restructuring+Proceedings+Under+CCAA+to+Implement+a+Review+of+its+Strategic+Alternatives/23522379.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that the Ontario Superior Court of Justice (Commercial List) (“Court”) has issued an initial order (“Initial Order”) granting the company protection under the <i>Companies’ Creditors Arrangement Act</i>, R.S.C. 1985, c. C-36, as amended (“CCAA”). The Initial Order provides for, among other things: (i) a stay of proceeding in favour of VBI, (ii) approval of the DIP Loan (as described below), and (iii) the appointment of Ernst &amp; Young Inc. (“EY”) http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Initiates+Restructuring+Proceedings+Under+CCAA+to+Implement+a+Review+of+its+Strategic+Alternatives/23522379.html Tue, 30 Jul 2024 09:55:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Initiates+Restructuring+Proceedings+Under+CCAA+to+Implement+a+Review+of+its+Strategic+Alternatives/23522379.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that the Ontario Superior Court of Justice (Commercial List) (“Court”) has issued an initial order (“Initial Order”) granting the company protection under the <i>Companies’ Creditors Arrangement Act</i>, R.S.C. 1985, c. C-36, as amended (“CCAA”). The Initial Order provides for, among other things: (i) a stay of proceeding in favour of VBI, (ii) approval of the DIP Loan (as described below), and (iii) the appointment of Ernst &amp; Young Inc. (“EY”) http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Initiates+Restructuring+Proceedings+Under+CCAA+to+Implement+a+Review+of+its+Strategic+Alternatives/23522379.html Tue, 30 Jul 2024 09:55:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Initiates+Restructuring+Proceedings+Under+CCAA+to+Implement+a+Review+of+its+Strategic+Alternatives/23522379.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that the Ontario Superior Court of Justice (Commercial List) (“Court”) has issued an initial order (“Initial Order”) granting the company protection under the <i>Companies’ Creditors Arrangement Act</i>, R.S.C. 1985, c. C-36, as amended (“CCAA”). The Initial Order provides for, among other things: (i) a stay of proceeding in favour of VBI, (ii) approval of the DIP Loan (as described below), and (iii) the appointment of Ernst &amp; Young Inc. (“EY”) http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Initiates+Restructuring+Proceedings+Under+CCAA+to+Implement+a+Review+of+its+Strategic+Alternatives/23522379.html Tue, 30 Jul 2024 09:55:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Initiates+Restructuring+Proceedings+Under+CCAA+to+Implement+a+Review+of+its+Strategic+Alternatives/23522379.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that the Ontario Superior Court of Justice (Commercial List) (“Court”) has issued an initial order (“Initial Order”) granting the company protection under the <i>Companies’ Creditors Arrangement Act</i>, R.S.C. 1985, c. C-36, as amended (“CCAA”). The Initial Order provides for, among other things: (i) a stay of proceeding in favour of VBI, (ii) approval of the DIP Loan (as described below), and (iii) the appointment of Ernst &amp; Young Inc. (“EY”) http://www.streetinsider.com/Press+Releases/VBI+Vaccines+Initiates+Restructuring+Proceedings+Under+CCAA+to+Implement+a+Review+of+its+Strategic+Alternatives/23522379.html Tue, 30 Jul 2024 09:55:00 -0400 A.29463531 A.36841346 O.00063920 O.00786521 O.34594121 VBIV